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ABSTRACT
Diabetes mellitus (DM) is a frequently experienced metabolic disease with chronic features and involves numerous complications around its course, 
which causes severe restriction and disability in an individual’s common life. It was stated that the incidence of depression is higher in diabetic patients 
and that diabetes is one of the risk factors in the development of depression. Depression has been shown to be correlated with poor self-management 
(adherence to diet and medication, physical exercise, and monitoring of blood glucose levels) and high HbA1C levels. The main intention of this article 
is to produce a comprehensive review of epidemiological findings, clinical attentions, and management approaches concerning depression in patients 
with DM.
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INTRODUCTION
The elevating stress of diabetes among adults (aged 20-70 years) is a 
major public health concern worldwide [1]. The number of diabetic 
patients is assumed to rise from 135 million in 1995 to 300 million in 
2025. Developing countries are expected to behold a 170% increase 
in the prevalence of diabetes correlated to 42% increase in developed 
countries. In 2025, over 75% of people having diabetes globally will be 
living in developing countries [2]. Particularly the prevalence of diabetes 
between Asian populations is increasing rapidly, compelled largely by 
economic development, nutrition transition, and torpid lifestyles. In 
2007, around 110 million individuals were affected with diabetes in Asia, 
with a young and middle-aged population that is affected excessively [3].
Type 2 diabetes mellitus (T2DM) states for the majority of all 
diabetes cases. T2DM has a number of incessant effects, including 
disability, cardiovascular disease (CVD), kidney disease, cataract, and 
blindness [1]. T2DM is also associated with clear decline in the quality 
of life (QOL) [4]. Comorbid depression, in addition, will reduce the 
QOL in people with T2DM [5], and is associated with poor treatment 
outcomes and lowered glycemic control [6,7]. Prevalence of depression 
is two-fold in people with T2DM compared to those without [8].
Depressive symptoms may thus be an important element of QOL in 
diabetes. Therefore, a study on the effect of depressive symptoms on 
QOL in individuals with diabetes is justified. This systematic review 
intent to explain this knowledge on the association of depressive 
symptoms with various forms of QOL in individuals with diabetes.
The intention of this review is to bring to light the presently available 
proof about some aspects of the co-occurrence of the two trembled 
diseases, namely, depression and diabetes, as both are frequently 
sustained together in regular clinical practice. The review largely 
centralized on the association of depression with poor glycemic control 
and diabetic complications as these are the determinants that have been 
found to form a fertile ground for the abandoned cycle of one leading 
to and exacerbating the other and poor control of either depression or 
diabetes when both exist together.
DIABETES AND DEPRESSION: THE BI-DIRECTIONAL ASSOCIATION
The association has been well established in diverse studies. The 
presence of diabetes approximately doubles the odds of comorbid 
depression, and this is observed across an ethnically different group of 
people [9]. The general risk estimate discerns across community and 
clinical settings regardless of differences in prevalence rates between 
these settings. Hence, the clinicians and the epidemiologists can cast 
individuals with diabetes to be twice as liable to be depressed as 
otherwise similar nondiabetic individuals [10]. Still, it has been noted 
that several factors stated to be linked to depression are not obstructed 
to those with diabetes and may be related to the general emotional or 
mental distress of having a chronic disease [11].
The connection between depression and diabetes has been disputed to 
be essentially bi-directional (Fig. 1).
Brown et al. through a study have come to an end that depression 
increases the risk of diabetes rather than vice-versa [12]. Factors such 
as physiological and behavioral properties seem to play an important 
role in the relationship between depression and diabetes. Depression 
is conceivably related to impaired glucose tolerance and obesity [13]. 
And also, poor health behaviors such as smoking, physical inactivity, 
and caloric consumption found in depressed individuals may increase 
the risk of diabetes type 2 [14]. Depression is found to have association 
with mental or emotional abnormalities such as arousal of the 
hypothalamic–pituitary–adrenal axis, sympathoadrenal organization, 
and pro-inflammatory cytokines that will acquire an insulin resistance 
and contribute to diabetes risk [15].
Mezuk et al. conducted a study and reported a comparative risk of 1.62 
for developing type 2 diabetes in patients with depression and a reliant 
risk of 1.21 for developing depression in diabetic patients [16].
ALTERED MENTAL STATUS BETWEEN PATIENTS WITH DM
Patients with DM seem not to be in higher risk for a mental disorder in 
general correlated to nondiabetic individuals.
Kruse et al. [17] did a cross-sectional population-based study of 141 
diabetic patients, identified from a community sample of 4169 people, 
the prevalence of any mental disorder - assessed with the Composite 
International Diagnostic Interview (CIDI) - was commensurable 
between the patients having DM and the nondiabetic individuals 
(26.61% vs. 26.02%). After making changes for age limits, gender, 
socioeconomic status and family status, insignificant difference 
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between the two groups were found, only anxiety disorders were found 
to be significantly more prevalent in the diabetic group with OR=2.051; 
CI: 1.23-3.44.
Das-Munshi et al. [18] in another cross-sectional population-based 
study of 249 patients with diabetes, noticed out of a sample of 8580 
individuals, the prevalence of any mental disorder - computed with the 
clinical interview schedule-revised was 21.62% in the diabetic group 
versus 16.32% in the nondiabetic group. The unadjusted odds ratio 
was nonsignificant (OR=1.4; CI: 1.01-2.02), but after adjustment of age, 
sex, and socioeconomic status emerged significant (OR=1.50; 1.11-
2.20; p<0.05). At the end, even after adjusting further for impairment 
in everyday functioning and medical comorbidity, the odds ratio was 
constricted again in nonsignificant levels. Same pattern was applied 
to mixed anxiety and depression, whereas the odds ratio regarding 
depressive, anxiety and comorbid anxiety-depressive disorders were 
not statistically meaningful throughout all the models applied, adapting 
for the confounders referred.
DEPRESSION
Prevalence and relative risk
The preponderance of major depression in patients with DM is mostly 
accounted around 12% (ranging from 8% to 18%), while temperate 
types of depression or elevated depressive symptoms, in general, are 
detected to be present in 16-35% (Table 1).
Compared to nondiabetic control community, patients with DM are 
reported to be about 1.3-3 times as expected to suffer from comorbid 
depression [18,26] although there have also been some studies - including 
the two fore mentioned [17,18] - that was unsuccessful to find out 
any genuine difference in the prevalence of depression (or affective 
disorders) between diabetic and nondiabetic individuals.
Pouwer et al. [19] suggested that the presence of comorbidities might 
be a significant factor contributing to the increased prevalence of 
depression in DM.
The concerning risk for the development of T2DM in depressed 
patients (depression→diabetes) is stated as high as 1.621. Conversely, 
pertaining to the relative risk for the development of depression in 
patients with DM (diabetes→depression), two recent meta-analyses of 
prospective studies have admitted a relative risk around 1.2 [16,35].
Estimates of the prevalence of depression change extensively depending 
on depression assessment tools (standardized interviews vs. self-
report questionnaires), classifications of depression (discerning major 
from minor depression or referring to increased depressive symptoms), 
study designs (controlled vs. uncontrolled), sample sizes and diabetes 
type. Exactly, depression is found at a rate of about 2-3 times higher 
when in self-report questionnaires compared to major depression 
being assessed with standardized interviews [26,10].
Depressive symptoms seem to be marginally very much prevalent in 
T2DM compared to those with T1DM (Table 1 and 2). Further studies, 
which compare the prevalence of depression in samples containing 
patients with diabetes of either type, adjusting for potential 
confounders, such as age, diabetic complications, diabetes duration, 
treatment regimen, glycemic control, and medical comorbidity are 
needed.
PREVALENCES, ODDS RATIOS, AND RISKS CONCERNING 
COMORBID DEPRESSION IN DIABETES
Persistence of depression in diabetic patients
Persistence or recurrence has been stated to extend widely in review 
studies the rates of depression, between 11.67% and 92.13%, depending 
on sample sizes, principle of depression diagnosis and classification of 
depression (major depression or elevated depressive symptoms).
Lustman et al. [40] done a follow-up in 25 patients who had taken part 
earlier in a 8-week depression treatment clinical trial with nortriptyline 
versus placebo. Persistence of depression was assessed using the 
Diagnostic Interview Schedule and thus found out in 23 patients (92%), 
with an average of 4.8 depressive episodes over the 5-years of follow-up. 
Recurrence was so common (80% of the patients) and rapid (58.3% 
of the patients were depressed again within the first year) even after 
successful initial treatment of depression. At the time of review among 
the patients, major depression was found to be possible in 65.56% of 
the patients, and glycemic control was extremely worse in this group 
of patients when compared with those who are without depression. 
19 patients (82.63%) those who relapsed had received extra courses 
of antidepressant treatment, but none was treated continuously for 
depression precaution.
A randomized controlled trial was conducted by Katon et al. [41] in 
164 diabetic patients assigned to collaborative care intervention and 
then compared to 165 diabetic patients assigned to usual care, and 
he concluded that depressive symptoms - assessed with Hopkins 
Symptoms Checklist 90 (SCL-90) show that there is a persistence of 
depression in 59.90% of the intervention group when cross checked 
with 68.37% of the usual care group at the 12-month follow-up.
Fischer et al. [26] conducted a study among 508 patients with T2DM 
evaluated 3 times over 18 months with a baseline of 9 months and 
18 months. Major depression was driven out with CIDI and found 
its presence in 14.9% of the patients at baseline and in 19.8% at any 
point during the study period. Major depression was persisted at 
all three estimated points in 11.6% of the patients diagnosed with 
major depression at baseline during diagnosis. Increased depressive 
symptoms were existing in 15.53% of the diabetic patients at baseline 
and in 34.42% at any point during the study. Increased depressive 
symptoms were prevailed at all three evaluation points in 58.12% of 
the patients with increased depressive symptoms at baseline. Thus, 
these findings indicated that prevalence of depression over time 
chiefly refers to increasing depressive symptoms rather than the major 
depression itself.
Katon et al., [42] in a prospective study among 2759 diabetic patients 
who were followed up for 5 years and thus found that 83.01% of the 
patients with major depression founded for reporting ≥5 symptoms 
in Patient Health Questionnaire-9 (PHQ-9), including at least one 
core symptom of depression, such as depressed mood at follow-up 
had also been depressed at baseline, while 42.43% of them had also a 
positive experiences of depression based on the previous International 
classification of diseases (ICD-9) registry codes within a period of 
18 months before the study.
Thus, we can conclude that depression is highly persistent and/or 
recurrent in DM, even after successful prior treatment. Thus, diabetic 
patients with a history of a depressive episode ever before should 
be deliberated at increased risk for reversion, especially under the 
influence of health-related or psychosocial stressors.
Fig. 1: Bidirectional relationship between comorbid depression 
and diabetes
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RISK FACTORS RESPONSIBLE FOR THE EVOLUTION OF 
DEPRESSION IN DIABETIC PATIENTS
Female sex, younger age, not having a partner, poor social support, 
lower education, low socioeconomic status, poor glycemic control, 
presence of diabetic complexities, presence of medical comorbidity, 
physical deterioration, and previous history of depression are the major 
risk factors associated with the presence of depression in patients with 
diabetes [20-22,42].
Pouwer et al., [19] conducted a controlled community-based study in 
216 patients with T2DM, observed from a sample of 3107 individuals 
(age range 55-85), and cross-checked the association of various 
factors with depression that are assessed both with CIDI and Center 
for Epidemiological Studies-Depression (CESD) scales using a 4-layer 
stepwise linear regression procedure, with demographics, clinical 
characteristics such as eye difficulties, CVD, other chronic medical 
diseases, medical comorbidity, functional limitations, social support, 
and perceived mastery over the disease were entered successively 
into the analysis. In the final model, they recognized the following 
risk factors being freely associated with depression. The female 
gender arose significantly associated with depression only in the 
first model. An association between depression and being unmarried 
arose as significant in the second and third model but ended up as 
marginally nonsignificant (p=0.058) again in the final model. Thus, 
indicated clinical characteristics were not significantly associated with 
depression in any of the stepwise regression models.
Egede and Ellis [28], in a large-scale cross-sectional study conducted 
among 16754 patients with DM, judged the differences among the three 
groups in which they created divisions in the sample by depression 
severity rating, according to PHQ-8 questionnaire scores. They found 
out indicative unsimilarities among the three groups by concerning 
race (four race groups), gender (females), age group (four classes), 
education status (four classes), assets (four classes), marital status 
(married), job status (employed), and allowance (insured), while no 
significant differences were found concerning health provider and 
diabetes education. The differences found across the subgroups of the 
variables with more than two classes cannot be determined by the Chi-
square analysis.
In a prospective study by Katon et al., [42] the following risk factors 
for major depression were found out: A previous history of depression 
increased diabetes-related symptoms at baseline and cardiovascular 
procedures during the study. The presence of a history of depression 
is a significant factor that should be adjusted for a while evaluating 
risk factors associated with the development of depression in DM. 
The use of medication with a potential depressogenic effect is another 
factor that has not been sufficiently taken into accounts, such as certain 
antihypertensive agents for precedent that are often prescribed in 
patients with DM and comorbid hypertension.
SELF-CARE
Gonzalez et al. [43] in a meta-analysis of 43 studies came to a conclusion 
that depression was negatively associated with adherence to DM 
treatment regimen, based on almost all self-care aspects evaluated 
such as dietary intake, medication, exercise, self-monitoring of blood 
glucose level, medical appointment attendance and composite self-care 
measures, not including diabetic foot care.
Researcher’s reports show that the type of diabetes did not seem 
to significantly affect the association between depression and 
nonadherence, and studies among children or adolescents with 
diabetes reported larger effects than studies among adults.
Gonzalez et al. [44] followed up 128 patients with DM for 9 months 
and concluded that, after modifying baseline self-care - assessed 
with diabetes self-care activities questionnaire, patients with higher 
depressive illness assessed with Harvard Department of Psychiatry 
showed lower attachment to general diet recommendations and 
specific dietary behaviors such as fruits and vegetables consumption 
Table 2: Systematic reviews and meta‑analyses







Both 20 studies (9 controlled)
11 studies did not contain 
comparison group
Systematic review 14.6% Gavard et al. [36] 1993
T1DM and T2DM 42 studies (20 controlled) Medline and psycINFO 
database
Chi statistics and odds 
ratio
11.4%
Elevated depressive symptoms: 31%
Controlled studies: 20.6% versus 
11.3%; OR=2.0
Uncontrolled studies: 29.7%
T1DM: OR=2.9 (1.6-5.5), 
T2DM: OR=2.9 (2.3-3.7) 
Overall: OR=2.0 (1.8-2.2)
Not dependent of sex, DM type, sample 
source, depression assessment method
Anderson et al. [10] 2001
T1DM 144 adolescents 27 item self-report 
questionnaire
20% of youth with DM to<7% of youth 
without DM
Grey et al. [37] 2002






12% versus 3.2% (controlled studies)
13.4% (uncontrolled studies)
Barnard et al. [38] 2006
T2DM 10 controlled studies 
including a total of 51,331 
people




The prevalence of depression was higher 
in females with DM (23.8%) compared 
with males (12.8%)
Ali et al. [39] 2006
T2DM 7 prospective studies Medline RR=1.15 (1.02-1.30) Mezuk et al. [16] 2008
T2DM 11 prospective studies Medline, embase and 
psycINFO database
RR=1.24 (1.09-1.40) Nouwen et al. [35] 2010
T2DM: Type 2 diabetes mellitus, DM: Diabetes mellitus, OR: Odds ratio, RR: Relative risk
AQ3
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and spacing of carbohydrates, less physical activity, and poorer foot 
care at follow-up.
Katon et al. [45] in a prospective study among 4117 patients with 
diabetes, found that major depression announced as reporting ≥5 
symptoms in PHQ-9 questionnaire, which includes at least 1 core 
evidence of depression, such as depressed mood or anhedonia was 
correlated with an increased likelihood of poor adherence to treatment 
concerning control of DM, hypertension and low-density lipoproteins.
Wagner et al. [46] conducted a study on 125 African American diabetic 
adults who were attending health fairs stated demographic and 
medical and medication history and provided blood samples for A1c 
assessment of glycemic control. He investigated the relationship between 
depressive symptoms and glycemic control, the relationship between 
depressive symptoms and long-term diabetes complications, the effects 
of demographic and diabetes variables on these relationships and the 
relationship between depressive symptoms and medication usage. Results 
show that higher depressive symptoms were related with elevated HbA1C, 
more long-term diabetes complications, and more diabetes medications. 
Diabetes self-care did not completely account for these relationships.
DIABETES-RELATED SYMPTOMS
Diabetes-related symptoms are more frequently stated in patients with 
comorbid depression.
Ciechanowski et al. [47] found that depression that is assessed with 
SCL-90R, as well as higher levels of diabetic complications, were 
independently affiliated with the amount of diabetes-associated 
symptoms reported for both T1DM and T2DM.
Ludman et al. [48] in a study among 4168 patients with DM, found 
that the symptoms associated with diabetes were assessed with 
self-completion patient outcome instrument was decidedly higher 
(mean = 4.40) in patients with major depression described by ≥5 
symptoms in PHQ-9 scale, including at least one core sign or symptom 
of depression, such as depressed mood or anhedonia - against patients 
without depression (mean = 2.46).
McKellar et al., [49] in a study among 307 patients with T2DM reviewed 
over 1 year and found that baseline depressive symptoms - evaluated 
with CESD and the mental health subscale of mental outcome studies 
36-short form anticipated the diabetes-related symptoms which 
are categorized as hyperglycemic, hypoglycemic, and microvascular, 
changes over the follow-up period. However, when self-care cohesion 
was entered in the structural equation model, the relationship between 
depressive and diabetes-related symptoms stayed no longer significant 
which indicates that the negative collision of depressive symptoms 
on diabetes-related symptoms is indirect, probably mediated by the 
negative collision of depression on diabetes self-care.
DIABETIC COMPLICATIONS
A meaningful association between depression and diabetic 
complications has been recognized.
According to a meta-analysis by de Groot et al., [50] the effect sizes 
for each complexity were as given as: 0.17 for retinopathy, 0.20 for 
macrovascular complexities, 0.25 for nephropathy, 0.28 for neuropathy, 
and 0.32 for sexual dysfunction. The overall effect size was small to 
moderate (r=0.25), commensurable between the two types of diabetes. 
The majority of studies on the relation between depression and 
diabetic complications have been cross-sectional, thus making causality 
difficult to conclude. However, prospective studies have presented that 
depression is associated with a higher and more rapid incidence of 
diabetic complications (Table 3).
Black et al. [55] studied combined effects of depression and diabetes 
on the incidence of adverse health outcomes among 2,830 Mexican 
Americans aged ≥65 years. Longitudinal data from the EPESE survey 
were used to examine the main effects and interaction effects of 
diabetes and depressive symptoms he found synergetic interaction 
of diabetes and depression, predicting greater mortality, greater 
occurrence of both macro- and microvascular complications, and 
greater incidence of restriction in activities of daily life, even when 
controlling for sociodemographic characteristics such as gender, age, 
educational status, and marital status.
A study conducted by Thour et al., [34] assessed the prevalence of 
comorbidities in 73 subjects. The mean age of study population was 
50.8±9.2 years. 57.5% of the subjects were females. 38.4% were from 
rural area. 60% of them had coexistent hypertension. About 40% had at 
least one microvascular complications.
The associations between depression and diabetic complications 
appear to be bi-directional, since depression might be a result with 
poor glycemic control as an intermediator - in advanced course of 
complications on one hand, while on the other hand, complexities 
might also have a contradictory impact on patient’s physical and mental 
health and QOL, thus promoting the development of depression.
COGNITIVE IMPAIRMENT
According to a systematic review of prospective studies by Cukierman 
et al. [56] People with diabetes have been reported to be at 60% 
increased the risk of developing dementia.
Mixed results were produced from studies evaluating the impact of 
depression on cognitive impairment in patients with DM.
Bruce et al. [57] assessed the longitudinal predictors of dementia in a 
study conducted between 302 patients with DM. Dementia after review 
was found not significantly associated either with depression at check 
out (cross-sectional) or with depression at baseline (longitudinal).
Katon et al., [58] in a prospective cohort study of 3837 primary care 
diabetic patients, over a 5-year follow-up period, evaluated the impact 
of depression on the risk for developing dementia. They found a 
significantly increased incidence of dementia (21.52 per 1000 person) 
in DM patients and major depression at baseline distinguished with DM 
patients but no depression at baseline (incidence rate of 11.81 per 1000 
person). Thus, comorbid major depression in DM was prospectively 
associated with a three-fold increased probability of dementia.
Katon et al. [59] governed a prospective cohort study in 3,837 
primary care patients with diabetes (mean age 63.2±13.2 years) 
registered in an HMO in Washington State. Depression at baseline 
was determined using the PHQ-9, and ICD-9 diagnoses for dementia 
were used to identify cases of dementia. Over the 5-year period, 
36 of 455 (7.9%) patients with major depression and diabetes 
(occurrence rate of 21.5 per 1,000 person-years) versus 163 
of 3,382 (4.8%) patients with diabetes alone (occurrence rate 
of 11.8 per 1,000 person-years) had one or more ICD-9 diagnoses 
of dementia. Thus, he concluded that patients with comorbid major 
depression had an increased exposure of dementia (fully adjusted 
hazard ratio 2.69, 95%; CI: 1.77, 4.07).
ASSOCIATION OF OBESITY
Mellal et al. [60] in a study about the prevalence of depressive symptoms 
and its socioeconomic determinants among university students 
in Al Ain, UAE found that the prevalence of depression was 22.2% 
among the study sample. Age seems to be associated with a significant 
difference in the prevalence of depression with the highest rate in the 
age group 17-25. Students those who asserted facing financial problems 
had a significant higher prevalence of depression. Finally, students’ 
ideas to their weight were associated with a significant influence on the 
prevalence of depression. Those who demanded being overweight had 
a significant higher prevalence of depression.
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Arafat et al. [61] in a study about the association of type 2 diabetes 
with obesity and other factors: In multinational community found a 
significant difference between the presences of type 2 diabetes in obese 
volunteers when compared to that of nonobese volunteers regardless 
of their age, race, and gender. However, the study showed that gender, 
age, race, family history with type 2 diabetes, and quality of food taken 
as one of the contributed factors that can induce type 2 diabetes, even 
in the nonobese adults.
CONCLUSION
Depression is common in both types 1 and 2 diabetes and has a 
significant role on the course and outcome of this medical illness. In 
a primary care population, diabetes self-care was suboptimal across 
a continuation from home-based activities, such as healthy eating, 
workout, and medication adherence, to use of preventive care. Major 
depression was chiefly associated with patient-initiated behaviors that 
are not easy to support (e.g., exercise, diet, and medication adherence) 
but not with preventive services for diabetes. Depression is a matter 
of great concern in patients with DM. It is not only highly accepted, 
but also highly persistent and recurrent causing a significant negative 
impact on both clinical outcomes and QOL. Besides, impaired QOL, it 
further deteriorates clinical outcomes and has been prospective leads to 
increased mortality in DM. Frequency of primary care visits (≥7), female 
gender, poor self-rated physical health, panic attacks, and dysthymia 
were agents independently associated with increased probability 
for correct depression recognition. Cuming to the management of 
depression in DM, psychotherapy combined with psychoeducational 
interventions or collaborative care seem to be cost-effective and yield 
beneficial and good results, both on mental health outcomes as well as 
diabetes management and glycemic control.
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